128 related articles for article (PubMed ID: 28514928)
1. Challenges in evaluation of screening for gastric cancer among men based on nonrandomized design.
Vohlonen I; Härkönen M; Malila N; Pukkala E; Sipponen P; Koistinen V; Hakama M
Acta Oncol; 2017 Jul; 56(7):917-922. PubMed ID: 28514928
[TBL] [Abstract][Full Text] [Related]
2. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group.
Varis K; Sipponen P; Laxén F; Samloff IM; Huttunen JK; Taylor PR; Heinonen OP; Albanes D; Sande N; Virtamo J; Härkönen M
Scand J Gastroenterol; 2000 Sep; 35(9):950-6. PubMed ID: 11063155
[TBL] [Abstract][Full Text] [Related]
3. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
Scand J Gastroenterol; 2019 Feb; 54(2):145-151. PubMed ID: 30700174
[TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.
Laiyemo AO; Kamangar F; Marcus PM; Taylor PR; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol; 2009 Nov; 33(5):368-73. PubMed ID: 19800305
[TBL] [Abstract][Full Text] [Related]
5. Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up.
Vohlonen I; Pukkala E; Malila N; Härkönen M; Hakama M; Koistinen V; Sipponen P
Scand J Gastroenterol; 2016 Oct; 51(10):1159-64. PubMed ID: 27338132
[TBL] [Abstract][Full Text] [Related]
6. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
Di Mario F; Moussa AM; Dal Bò N; Caruana P; Pilotto A; Cavallaro LG; Cavestro GM; Iori V; Merli R; Franzé A; Rugge M
J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
[TBL] [Abstract][Full Text] [Related]
8. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
9. [Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 2011].
Yuan Y
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):538-42. PubMed ID: 22967474
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of screening for gastric cancer using serum pepsinogen concentrations.
Kitahara F; Kobayashi K; Sato T; Kojima Y; Araki T; Fujino MA
Gut; 1999 May; 44(5):693-7. PubMed ID: 10205207
[TBL] [Abstract][Full Text] [Related]
11. Serum pepsinogen test for early detection of gastric cancer in a European country.
Lomba-Viana R; Dinis-Ribeiro M; Fonseca F; Vieira AS; Bento MJ; Lomba-Viana H
Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):37-41. PubMed ID: 21989121
[TBL] [Abstract][Full Text] [Related]
12. Atrophic gastritis and the risk of incident colorectal cancer.
Laiyemo AO; Kamangar F; Marcus PM; Taylor PR; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Causes Control; 2010 Jan; 21(1):163-70. PubMed ID: 19838812
[TBL] [Abstract][Full Text] [Related]
13. Serum pepsinogen and gastric cancer screening.
Mukoubayashi C; Yanaoka K; Ohata H; Arii K; Tamai H; Oka M; Ichinose M
Intern Med; 2007; 46(6):261-6. PubMed ID: 17379991
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
15. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
16. Western long-term accuracy of serum pepsinogen-based gastric cancer screening.
Castro C; Dinis-Ribeiro M; Rodrigues ANG; Calheiros T; Santos J; Pereira P; Ramos M; Cunha H; Andrade M; Costa A; Sá L; Antunes L; Bento MJ; Lomba-Viana R
Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):274-277. PubMed ID: 29215432
[TBL] [Abstract][Full Text] [Related]
17. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
19. Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study.
Chiang TH; Chiu SY; Chen SL; Yen AM; Fann JC; Liu CY; Chou CK; Chiu HM; Shun CT; Wu MS; Lin JT; Lee YC; Chen TH; Lin MW
J Clin Gastroenterol; 2019; 53(5):e186-e193. PubMed ID: 29369241
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
